Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) remains one of the most common malignant tumours worldwide. Therefore, the identification and development of sensitivity- genes as novel diagnostic markers and effective therapeutic targets is urgently needed. Dopamine and dopamine receptor D1 (DRD1) are re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhihui, Wen, Peihao, Hu, Bowen, Cao, Shengli, Shi, Xiaoyi, Guo, Wenzhi, Zhang, Shuijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557590/
https://www.ncbi.nlm.nih.gov/pubmed/34717619
http://dx.doi.org/10.1186/s12935-021-02298-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557590/
https://www.ncbi.nlm.nih.gov/pubmed/34717619
http://dx.doi.org/10.1186/s12935-021-02298-9

Ejemplares similares